Home Cart Sign in  
Chemical Structure| 154-17-6 Chemical Structure| 154-17-6

Structure of 2-Deoxy-D-glucose
CAS No.: 154-17-6

Chemical Structure| 154-17-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

2-Deoxy-D-glucose is a glucose analog that inhibits glycolysis by targeting hexokinase.

Synonyms: 2-DG; 2-Deoxy-D-arabino-hexose; Ba 2758

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of 2-Deoxy-D-glucose

CAS No. :154-17-6
Formula : C6H12O5
M.W : 164.15
SMILES Code : O=CC[C@H]([C@@H]([C@@H](CO)O)O)O
Synonyms :
2-DG; 2-Deoxy-D-arabino-hexose; Ba 2758
MDL No. :MFCD00151328
InChI Key :VRYALKFFQXWPIH-PBXRRBTRSA-N
Pubchem ID :108223

Safety of 2-Deoxy-D-glucose

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
human mesenchymal stem cells (hMSCs) 5 mM 48 h inhibit glycolysis, measure the ratio of glycolytic ATP PMC7738682
U87MG 5 mM 20 min To measure ATP utilization in cells under hypoxic acidosis conditions. The results showed that 2-Deoxy-D-glucose inhibited ATP production. PMC7666154
SH-SY5Y cells 10 μM 10 min To assess glucose uptake in SH-SY5Y cells, results showed that both IL-6 and insulin treatments significantly increased glucose uptake. PMC7290332
HT22 cells 2 mM 30 min To assess mitochondrial function by inhibiting glycolysis to directly evaluate mitochondrial function PMC10410063
FHC cells 50 mM 24 h Measure the glycolytic capacity and mitochondrial function of cells, showing that CDC20-knockdown cells exhibited a significant increase in ECAR and a significant decrease in OCR. PMC7163048
RPE1 cells 50 mM 24 h Measure the glycolytic capacity and mitochondrial function of cells, showing that CDC20-knockdown cells exhibited a significant increase in ECAR and a significant decrease in OCR. PMC7163048

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Shank3/C0//C0 mice Intraperitoneal injection 2.5 mg/10 g Five consecutive days Blocking glycolysis partially rescued synaptic and social deficits in these ASD models. PMC10245038
Mice MVT-1 breast cancer model Intraperitoneal injection 1 g/kg Daily for two weeks To investigate the effect of 2DG on tumor necroptosis, results showed that 2DG significantly reduced MLKL phosphorylation in MVT-1 tumors PMC8113527
Mice MCUfl/fl mice Intraperitoneal injection 0.027 g/kg Single injection To measure the uptake of 2-deoxy-D-glucose in muscles and liver, results showed increased uptake in muscles and decreased uptake in liver in MCU-deficient mice. PMC6329801

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00633087 Prostate Cancer PHASE1|PHASE2 TERMINATED 2025-03-11 The Cancer Institute of New Je... More >>rsey, New Brunswick, New Jersey, 08901, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

6.09mL

1.22mL

0.61mL

30.46mL

6.09mL

3.05mL

60.92mL

12.18mL

6.09mL

References

 

Historical Records

Categories